Ubs Group Ag Si Bone, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Si Bone, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 19,475 shares of SIBN stock, worth $280,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,475

Previous 36,308 46.36%

Holding current value

$280,440

Previous $469,000 42.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.9 - $17.11 $217,145 - $288,012	-16,833 Reduced 46.36%	19,475 $272,000
Q2 2024 Aug 13, 2024	SELL	$11.93 - $16.34 $383,943 - $525,870	-32,183 Reduced 46.99%	36,308 $469,000
Q1 2024 May 13, 2024	BUY	$15.15 - $21.58 $168,725 - $240,336	11,137 Added 19.42%	68,491 $1.12 Million
Q4 2023 Feb 09, 2024	BUY	$15.75 - $21.38 $401,971 - $545,660	25,522 Added 80.18%	57,354 $1.2 Million
Q3 2023 Nov 09, 2023	BUY	$20.22 - $27.36 $15,549 - $21,039	769 Added 2.48%	31,832 $676,000
Q2 2023 Aug 11, 2023	BUY	$19.39 - $28.9 $544,955 - $812,234	28,105 Added 950.14%	31,063 $838,000
Q1 2023 May 12, 2023	SELL	$12.71 - $21.17 $115,012 - $191,567	-9,049 Reduced 75.36%	2,958 $58,000
Q4 2022 Feb 08, 2023	BUY	$11.23 - $19.44 $80,373 - $139,132	7,157 Added 147.57%	12,007 $163,000
Q3 2022 Nov 10, 2022	BUY	$12.2 - $18.71 $13,481 - $20,674	1,105 Added 29.51%	4,850 $84,000
Q2 2022 Aug 10, 2022	SELL	$12.05 - $22.74 $5,085 - $9,596	-422 Reduced 10.13%	3,745 $49,000
Q1 2022 May 16, 2022	SELL	$18.32 - $23.03 $126,096 - $158,515	-6,883 Reduced 62.29%	4,167 $95,000
Q4 2021 Feb 14, 2022	BUY	$18.75 - $24.8 $203,325 - $268,931	10,844 Added 5264.08%	11,050 $245,000
Q3 2021 Nov 15, 2021	BUY	$19.65 - $31.89 $3,045 - $4,942	155 Added 303.92%	206 $4,000
Q2 2021 Aug 13, 2021	SELL	$29.4 - $35.96 $234,523 - $286,852	-7,977 Reduced 99.36%	51 $2,000
Q1 2021 May 12, 2021	BUY	$28.09 - $34.02 $63,736 - $77,191	2,269 Added 39.4%	8,028 $255,000
Q4 2020 Feb 11, 2021	BUY	$20.44 - $30.88 $106,042 - $160,205	5,188 Added 908.58%	5,759 $172,000
Q3 2020 Nov 12, 2020	SELL	$15.68 - $24.28 $141,041 - $218,398	-8,995 Reduced 94.03%	571 $13,000
Q2 2020 Jul 31, 2020	SELL	$10.56 - $18.46 $18,142 - $31,714	-1,718 Reduced 15.23%	9,566 $152,000
Q1 2020 May 01, 2020	SELL	$8.36 - $22.67 $72,823 - $197,478	-8,711 Reduced 43.57%	11,284 $135,000
Q4 2019 Feb 14, 2020	BUY	$15.73 - $21.81 $130,433 - $180,848	8,292 Added 70.85%	19,995 $430,000
Q3 2019 Nov 14, 2019	BUY	$17.15 - $20.26 $119,449 - $141,110	6,965 Added 147.0%	11,703 $206,000
Q2 2019 Aug 14, 2019	BUY	$15.13 - $20.34 $69,809 - $93,848	4,614 Added 3720.97%	4,738 $96,000
Q1 2019 May 14, 2019	SELL	$17.29 - $22.35 $67,275 - $86,963	-3,891 Reduced 96.91%	124 $2,000
Q4 2018 Feb 14, 2019	BUY	$16.79 - $21.0 $67,411 - $84,315	4,015 New	4,015 $84,000

Others Institutions Holding SIBN

# of Institutions

141

Shares Held

41.4M

Call Options Held

266K

Put Options Held

252K

View Full List

About SI-BONE, Inc.

Ticker SIBN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,305,000
Market Cap $494M
Description
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...

More about SIBN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account